Insider · CIK 0001724346

Kaseta Michael

Reports to the SEC for 4 companies · MORRISVILLE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001724346

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-12	LQDALiquidia CorpS Sale	CFO and COO	SSale	−18.9K sh	$28.48	−$539K	340,148
2026-10-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+5,828 sh	—	—	352,037
2026-10-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+7,049 sh	—	—	359,086
2026-10-09	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−5,828 sh	—	—	29,140
2026-10-09	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−7,049 sh	—	—	63,448
2026-07-13	LQDALiquidia CorpS Sale	CFO and COO	SSale	−1,453 sh	$71.39	−$104K	364,782
2026-07-13	LQDALiquidia CorpS Sale	CFO and COO	SSale	−19K sh	$71.52	−$1.36M	345,805
2026-07-10	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+5,829 sh	—	—	359,185
2026-07-10	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+7,050 sh	—	—	366,235
2026-07-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−5,829 sh	—	—	34,968
2026-07-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−7,050 sh	—	—	70,497
2026-04-15	LQDALiquidia CorpS Sale	CFO and COO	SSale	−9,044 sh	$40.14	−$363K	396,731
2026-04-15	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+87K sh	$2.79	+$243K	483,702
2026-04-15	LQDALiquidia CorpS Sale	CFO and COO	SSale	−87K sh	$40.14	−$3.49M	396,731
2026-04-15	LQDALiquidia CorpS Sale	CFO and COO	SSale	−43.4K sh	$40.14	−$1.74M	353,356
2026-04-15	LQDALiquidia Corp · Incentive Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−87K sh	—	—	10,534
2026-04-14	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+3,000 sh	$2.79	+$8,370	408,775
2026-04-14	LQDALiquidia CorpS Sale	CFO and COO	SSale	−3,000 sh	$40.00	−$120K	405,775
2026-04-14	LQDALiquidia Corp · Incentive Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−3,000 sh	—	—	97,505
2026-04-13	LQDALiquidia CorpS Sale	CFO and COO	SSale	−19K sh	$38.37	−$727K	405,775
2026-04-10	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+23.8K sh	$2.79	+$66.5K	435,676
2026-04-10	LQDALiquidia CorpS Sale	CFO and COO	SSale	−23.8K sh	$40.14	−$956K	411,855
2026-04-10	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+5,828 sh	—	—	417,683
2026-04-10	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+7,050 sh	—	—	424,733
2026-04-10	LQDALiquidia Corp · Incentive Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−23.8K sh	—	—	100,505
2026-04-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−5,828 sh	—	—	40,797
2026-04-10	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−7,050 sh	—	—	77,547
2026-04-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+19K sh	$2.79	+$53.1K	430,897
2026-04-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+86.6K sh	$2.79	+$242K	517,529
2026-04-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+18.1K sh	$2.97	+$53.8K	535,644
2026-04-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+728 sh	$2.54	+$1,849.12	536,372
2026-04-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+9,272 sh	$2.54	+$23.6K	545,644
2026-04-09	LQDALiquidia CorpS Sale	CFO and COO	SSale	−134K sh	$40.24	−$5.38M	411,855
2026-04-09	LQDALiquidia Corp · Incentive Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−19K sh	—	—	124,326
2026-04-09	LQDALiquidia Corp · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−86.6K sh	—	—	0
2026-04-09	LQDALiquidia Corp · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−18.1K sh	—	—	0
2026-04-09	LQDALiquidia Corp · Incentive Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−728 sh	—	—	0
2026-04-09	LQDALiquidia Corp · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	CFO and COO	MExercise/Conversion	−9,272 sh	—	—	0
2026-03-02	LQDALiquidia CorpS Sale	CFO and COO	SSale	−1,165 sh	$30.58	−$35.6K	411,855
2026-02-27	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+2,344 sh	—	—	413,020
2026-02-27	LQDALiquidia Corp · Restricted Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−2,344 sh	—	—	0
2026-01-30	HRTXHERON THERAPEUTICS, INC. /DE/A Award	Director	AAward	+54K sh	—	—	53,960
2026-01-16	LQDALiquidia CorpA Award	CFO and COO	AAward	+59.3K sh	—	—	410,239
2026-01-16	LQDALiquidia Corp · Performance Stock UnitsA Award	CFO and COO	AAward	+89K sh	—	—	88,980
2026-01-12	LQDALiquidia CorpS Sale	CFO and COO	SSale	−36.9K sh	$37.43	−$1.38M	350,919
2026-01-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+5,828 sh	—	—	359,651
2026-01-09	LQDALiquidia CorpM Exercise/Conversion	CFO and COO	MExercise/Conversion	+28.2K sh	—	—	387,851
2026-01-09	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−5,828 sh	—	—	46,625
2026-01-09	LQDALiquidia Corp · Performance Stock UnitsM Exercise/Conversion	CFO and COO	MExercise/Conversion	−28.2K sh	—	—	84,597
2025-12-01	LQDALiquidia CorpS Sale	CFO and COO	SSale	−1,166 sh	$32.19	−$37.5K	353,823

Recent filings

Accepted (ET)
Oct 134
Kaseta Michael0001104659-26-115644
SEC(opens sec.gov)
Jul 144
Kaseta Michael0001104659-26-083620
SEC(opens sec.gov)
Apr 164
Kaseta Michael0001104659-26-044511
SEC(opens sec.gov)
Apr 144
Kaseta Michael0001104659-26-043269
SEC(opens sec.gov)

Companies

Address

419 DAVIS DRIVE, SUITE 100

MORRISVILLE, NC, 27560